Day: May 22, 2025

Geneva, Switzerland, May 22, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today shares an update on the exclusive negotiations entered to acquire 100% of the share capital and voting rights of IC’ALPS SAS (“IC’ALPS”), an Application-Specific Integrated Circuit (“ASIC”) design and supply specialist based in Grenoble, France (“the Acquisition”). These exclusive negotiations result from the execution of a Letter of Intent with IC’ALPS and its shareholders (the “Sellers”). This proposed strategic Acquisition (subject to the signing of a Share Purchase Agreement and satisfaction of closing conditions) is expected to reinforce SEALSQ’s commitment to advancing...

WISeKey Updates on the Negotiations to Acquire 100% of IC’ALPS Geneva, Switzerland – May 22, 2025 – Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules – WISeKey International Holding Ltd (NASDAQ: WKEY / SIX: WIHN) (“WISeKey” or “the Company”), a global leader in cybersecurity, digital identity, and IoT technologies, today shares an update on the exclusive negotiations entered into by its subsidiary, SEALSQ Corp (“SEALSQ”), a leading developer and provider of Semiconductors, PKI, and Post-Quantum technology hardware and software solutions, to acquire 100% of the share capital and voting rights of IC’ALPS SAS (“IC’ALPS”), an Application-Specific Integrated Circuit (“ASIC”) design and supply specialist based in Grenoble, France (“the Acquisition”). These exclusive negotiations result from the execution of...

Euronext announces the success of its offering of bonds due 2032 convertible into new shares and/or exchangeable for existing shares (“OCEANEs”) for a nominal amount of €425 million Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 22 May 2025 – Euronext (ISIN Code: NL0006294274) (the “Company”), the leading European capital market infrastructure, announces today the success of its offering of senior unsecured bonds due 2032 convertible into new shares and/or exchangeable for existing shares of the Company (“OCEANEs”) (the “Bonds”), by way of a placement to qualified investors only (within the meaning of Article 2(e) of the Prospectus Regulation (as defined below)), for a nominal amount of €425 million (the “Offering”). On 17 April 2025, the Company entered into a bridge loan facility with, among others, affiliates of the joint...

Exclusive luxury community includes access to expansive amenities in sought-after Lake Nona ORLANDO, Fla., May 22, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity to build a new home in Laurel Pointe, an exclusive community within the Lake Nona master plan in Orlando, Florida. Only a limited number of homes remain available for sale, including the stunning Marsanne Farmhouse model home. The final home sites in the community, including many that back up to a water conservation area, feature home designs from the Collage Collection in Laurel Pointe. This collection offers unique floor plans and stunning exterior designs, as well as high-end interiors including gourmet kitchens, spacious living areas, expansive primary bedroom suites, and smart...

Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months Susvimo’s innovative technology via the Port Delivery Platform may offer an alternative to regular eye injections in the US Diabetic retinopathy affects almost 10 million people in the US and is the third FDA-approved indication for Susvimo, which is also approved for treating neovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaBasel, 22 May 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic retinopathy (DR), a potentially blinding condition that affects almost 10 million people in the US and more than 100 million...

24-month follow-up data from randomized Phase I part of the Phase I/II trial of TG4050 in resected locally advanced head and neck cancer selected for rapid oral presentationat ASCO on June 1st, 2025 Strasbourg, France, May 22, 2025, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that it will present two-year disease-free survival (DFS) data from all patients in the randomized Phase I part of the trial of its individualized neoantigen therapeutic cancer vaccine TG4050. The data will be shared during a rapid oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago from May 30 to June 3, 2025. TG4050 is a viral vector-based immunotherapy based on Transgene’s myvac® platform...

REGULATED INFORMATION                Paris, 22 May 2025 5:45 PM YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION Availability of documents Annual shareholders’ meeting of June 12th, 2025 TOUAX informs its shareholders that its combined Annual Shareholders’ Meeting will be held on Thursday June 12, 2025 at 3:00 p.m. at Châteauform’ Learning Lab La Défense, 40 passage de l’Arche, 92800 Puteaux, France. The official meeting announcements have been published in the BALO (Bulletin des Annonces Légales Obligatoires) on May 7, 2025. Pursuant to Article 221-1 of the “Règlement général” of the “Autorité des marchés financiers”, information mentioned in Article R.225-83 of the French Commercial Code is already available to shareholders, in accordance with the applicable French laws and regulations, and under the following...

Following previous discussions between SKEL fjárfestingafélag hf. (“SKEL”) and Samkaup hf. (“Samkaup”) regarding a merger of Samkaup with Orkan IS ehf. (“Orkan”) and Atlaga ehf. (formerly Heimkaup), further discussions took place with Kaupfélag Suðurnesja svf. (“KSK”), the largest shareholder in Samkaup, about resuming the dialogue under new terms. This past December, the parties reached an agreement on a merger between Atlaga and Samkaup, a transaction that received competition authority approval in April. Today, a purchase agreement was signed between Orkan as the buyer and KSK as the seller for all of the seller’s shares in Samkaup, with a nominal value of ISK 221,386,719, representing 51.3% of Samkaup’s share capital. The purchase price of the shares is a total of ISK 2,878 million and is based on a valuation of Samkaup’s total equity...

Priority Pass members gain access to additional relaxing, time-saving treatments at U.S. airports NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), a leading provider of wellness solutions for people on the go, today announced the expansion of its partnership with Priority Pass, the world’s original airport experiences program. Through this expanded collaboration, Priority Pass members will now have access to a broader menu of wellness services at spa locations across the United States. “Through our partnership with Priority Pass, we’re expanding access to best-in-class wellness services that meet the evolving needs of today’s travelers,” said XWELL Chief Executive Officer Ezra Ernst. “This collaboration not only enhances the airport experience but also introduces our spa offerings...